Biotech Values

[turtlepower]

CLDX - Even if the N for G>50 was small it would have been interesting to see those numbers. If there weren't any in the IC arm a high RR in the CDX011 arm would have been confirmation that the the drug works well in the HG subgroup.

If they do end up enrolling patients with G >25 and TN patients then how long would the trial take to enroll? The current one took about 1.5 years and it had a pretty low entry criteria.